Ligand validation:3ZDQ

LMT: DODECYL-BETA-D-MALTOSIDE

LMT is a Ligand Of Interest in 3ZDQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZDQ_LMT_A_1724	55%	87%	0.166	0.933	0.23	0.45	-	-	1	0	100%	1
3ZDQ_LMT_A_1720	51%	90%	0.162	0.917	0.19	0.41	-	-	0	0	100%	1
3ZDQ_LMT_A_1723	7%	96%	0.312	0.882	0.2	0.17	-	-	1	0	34%	1
4AYT_LMT_A_1724	54%	87%	0.17	0.935	0.24	0.45	-	-	3	0	100%	1
4AYX_LMT_A_1724	37%	90%	0.198	0.898	0.23	0.38	-	-	3	0	100%	1
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
3CAY_LMT_A_512	99%	59%	0.04	0.975	0.66	0.9	-	1	0	0	100%	1
7M78_LMT_L_202	95%	44%	0.073	0.976	1.13	1.04	3	2	0	0	100%	1
3T2Y_LMT_A_501	83%	30%	0.085	0.943	1.26	1.54	3	10	2	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.